TAIPEI, Taiwan – Aslan Pharmaceuticals Pte. Ltd., a Singapore-based company focused on the development of treatments for prevalent tumor types in Asia, is conducting a competitive auction and public offer of common shares for its initial listing on the …
( read original story …)